Hu, Zhuting
Dana-Farber Cancer Institute
3 papers on CoChat
Most cited papers
- Verified
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 2,936
- Verified
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Keskin, D. B., Anandappa, A. J., Sun, J., Tirosh, I., Mathewson, N. D., Li, S., Oliveira, G., Giobbie-Hurder, A., Felt, K., Gjini, E., et al. (2019) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,432
- Verified
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 1,067
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free